why choose us

First received: June 12, 2024

Clinical Trial: Personalized Management of Type 2 Diabetes Using AI-Guided (GenAIS TM) Dietary Supplementation

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Diabetes

Study Type: INTERVENTIONAL


Official Title: Personalized Management of Type 2 Diabetes Using AI-Guided (GenAIS TM) Dietary Supplementation: A Randomized Controlled Clinical Trial

Brief Summary: This randomized controlled trial investigates the effectiveness of AI-guided dietary supplement prescriptions compared to standard physician-guided prescriptions in managing Type 2 diabetes (T2D).The study includes 160 participants with T2D, aged 40-75, who will be randomly assigned to either the control group (standard physician-guided prescriptions) or the AI-guided group (prescriptions determined by GenAIS, an AI system by Triangel Scientific).The primary objective is to compare the reduction in HbA1c levels…

Read more